Innovative Technologies for Molecular Analysis of Cancer
The summary for the Innovative Technologies for Molecular Analysis of Cancer grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Innovative Technologies for Molecular Analysis of Cancer: The National Cancer Institute (NCI) invites applications for research projects to evaluate the usefulness of emerging technologies that are ready for initial application to clinical or biological questions in cancer research. This RFA will use NIH R21 Exploratory/Developmental and the R33 Exploratory/Developmental Phase II award mechanisms. The R33 mechanism provides a second phase for the support of innovative exploratory and developmental research that may or may not have been initiated under the R21 mechanism. NCI intends to commit approximately $3,000,000 in FY 2006 to fund 10 to 15 new and/or competing continuation grants in response to this RFA. An applicant may request a project period of up to2 years and a budget for direct costs of up to $275,000, in keeping with standard R21 mechanism guidelines. An applicant may request a project period of up to 3 years for an R33. Because the nature and scope of the proposed research will vary from applicat! ion to application, it is anticipated that the size and duration of each award, especially in the case of R33 awards, will also vary. Budgets for R33 applications should be appropriate for the science proposed. An applicant may submit an unlimited number of unique applications in response to this announcement.
| Federal Grant Title: | Innovative Technologies for Molecular Analysis of Cancer |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Health Education |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-CA-06-002 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.39293.393 |
| CFDA Descriptions: | Cancer Construction 93.393 Cancer Cause and Prevention Research |
| Current Application Deadline: | No deadline provided |
| Original Application Deadline: | Multiple Receipt Dates - See Link to Full Announce |
| Posted Date: | Dec 13, 2004 |
| Creation Date: | Dec 13, 2004 |
| Archive Date: | Nov 18, 2005 |
| Total Program Funding: | $3,000,000 |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | 10 |
| Cost Sharing or Matching: | 93.394 -- Cancer Detection and Diagnosis Research |
- Applicants Eligible for this Grant
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Private institutions of higher education State governments County governments City or township governments Special district governments Independent school districts Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are eligible to apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster